Active, not recruitingPhase 2NCT06070116
Safety and Efficacy of Novel Combination Regimens for Treatment of Onchocerciasis
Studying Nodular fasciitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Washington University School of Medicine
- Principal Investigator
- Peter Fischer, PhDWashington University School of Medicine
- Intervention
- Ivermectin w/ Albendazole(drug)
- Enrollment
- 300 enrolled
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2024 – 2026
Study locations (1)
- Bong County Hospital, Bong Town, Bong County, Liberia
Collaborators
National Public Health Institute of Liberia
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06070116 on ClinicalTrials.gov